Cellebrite DI

Forecast & Rating7 analysts currently cover Cellebrite DI, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.00, about 43.4% upside from the current price of $14.64. Price targets range from $15.00 to $28.00 — a wide spread, showing clear disagreement over just how much Cellebrite DI can rise. Historically, about 76.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Cellebrite DI closely still see room for the stock to rise. Data as of Jul 13, 2026; for reference only and not investment advice.